Tobacco addiction: Implications for treatment and cancer prevention

Paul M. Cinciripini, Stephen S. Hecht, Jack E. Henningfield, Marc W. Manley, Barnett S. Kramer

Research output: Contribution to journalArticlepeer-review

Abstract

The American Society of Clinical Oncology and the National Cancer Institute convened a symposium in June 1996 on tobacco addiction. Additional support for the symposium was provided by the American Medical Women's Association and the American Society of Preventive Oncology. The goals of this conference were to describe the burden and public health consequences of tobacco addiction, to describe the state of science for the treatment of nicotine dependence, and to explore new strategies to increase quit rates and to prevent the uptake of tobacco use. This article summarizes and integrates the meeting presentations on tobacco addiction and includes the topics of smoking prevalence; psychobiologic aspects of nicotine dependence; and implications for disease, treatment, and prevention. Comments on regulatory approaches and national strategies for reducing dependence are also summarized in presentations by Dr. David Kessler, former Food and Drug Administration Commissioner, and Dr. C. Everett Koop, former U.S. Surgeon General.

Original languageEnglish (US)
Pages (from-to)1852-1867
Number of pages16
JournalJournal of the National Cancer Institute
Volume89
Issue number24
StatePublished - Dec 17 1997

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Tobacco addiction: Implications for treatment and cancer prevention'. Together they form a unique fingerprint.

Cite this